Home / GLAXO.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GLAXO.NS make money? Does GLAXO.NS have pricing power? What's the Earnings Whisper? Will GLAXO.NS profit more as the business scales? What is GLAXO.NS's management track record? Is GLAXO.NS's current price justified?

GlaxoSmithKline Pharmaceuticals Limited

₹2566.1 +$110.20 (+4.49%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹2524.7

Day Range

₹2518.4₹2573.2

Year Range

₹2088.1₹3120.7

Market Cap

434.71B

AVG Volume

115.32K

Trailing/Forward PE

40.7/31.93

PEG ratio

3.67

Dividend Yield

2.22%

Next Earnings Date

2026-11-03

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

GLAXO.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	9.38B
26 Q4	9.95B
26 Q3	10.41B
26 Q2	9.8B
26 Q1	8.05B
25 Q4	9.51B
25 Q3	9.49B
25 Q2	10.11B
25 Q1	8.15B
24 Q4	9.18B

Net Income (INR) · Q

GLAXO.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	2.37B
26 Q4	2.78B
26 Q3	2.96B
26 Q2	2.57B
26 Q1	2.05B
25 Q4	2.63B
25 Q3	2.3B
25 Q2	2.52B
25 Q1	1.82B
24 Q4	1.94B

Operating Income (INR) · Q

GLAXO.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	2.8B
26 Q4	3.38B
26 Q3	3.51B
26 Q2	3.18B
26 Q1	2.36B
25 Q4	3.22B
25 Q3	2.73B
25 Q2	3.05B
25 Q1	2.14B
24 Q4	2.39B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

GlaxoSmithKline Pharmaceuticals Limited

Video analysis: GLAXO.NS

News: GLAXO.NS

Similar companies